Skip to main content
Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.52
+0.58 (8.36%)
At close: Apr 28, 2026, 4:00 PM EDT
7.52
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:32 PM EDT

Wave Life Sciences Revenue

Wave Life Sciences had revenue of $38.25M in the quarter ending March 31, 2026, with 316.85% growth. This brings the company's revenue in the last twelve months to $71.80M, down -31.58% year-over-year. In the year 2025, Wave Life Sciences had annual revenue of $42.73M, down -60.55%.

Revenue (ttm)
$71.80M
Revenue Growth
-31.58%
P/S Ratio
19.99
Revenue / Employee
$226,492
Employees
317
Market Cap
1.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202542.73M-65.58M-60.55%
Dec 31, 2024108.30M-5.00M-4.42%
Dec 31, 2023113.31M109.66M3,005.10%
Dec 31, 20223.65M-37.32M-91.09%
Dec 31, 202140.96M20.89M104.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novavax 1.12B
Iovance Biotherapeutics 263.50M
AbCellera Biologics 75.13M
Viridian Therapeutics 70.85M
Precigen 9.68M
Revenue Rankings

WVE News

More News